Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms

Trima Pharmaceuticals

Status: Completed

Conditions: Dry Eye Syndrome

Treatments: Drug: Tears Again

Study type: Interventional

Funder types: Industry

Identifiers

NCT00535054

06.11

Details and patient eligibility

About

The purpose of this study is to determine safety and patients' satisfaction when using Tears Again to treat Dry Eye Symptoms.

Enrollment: 125 estimated patients

Sex: All

Ages: 25 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Suffer from at least two of the following ocular symptoms: burning, stinging, excessive tearing, dryness, grittiness, foreign body sensation ( including patients suffering from blepharitis).
• Use artificial tears or any other treatment for these symptoms three or more times a day.

Exclusion criteria

• Known hypersensitivity to Phenoxyethanol.
• Pregnant and lactating women.
• Receive other ophthalmic medication (except for eyelid hygiene preparations).
• Graft-versus-host disease patients.
• Participated during the last month in another clinical trial.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

125 participants in 1 patient group

Tears Again

Experimental group

Description:

All subjects shall be treated with Tears Again.

Treatment:

Drug: Tears Again